Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly
Research Square (Research Square)(2020)
摘要
Abstract Background: Mid-life obesity is related to increased risk for overall dementia and Alzheimer´s disease (AD) dementia. In the present work, we aimed to investigate the impact of obesity on brain structure, metabolism, and cerebrospinal fluid (CSF) biomarkers of amyloid (Aβ 1-42) and tau-pathology (total-tau and p-tau) in healthy elderly. Methods: We selected healthy controls from ADNI2 with available CSF AD biomarkers and/or fluorodeoxyglucose (FDG) PET and 3T-MRI. Participants without follow-up or with significant weight loss were excluded from the analyses. Brain cortical thickness (Cth) was evaluated with Freesurfer software and FDG uptake was measured with a surface-based method using both SPM and Freesurfer softwares. We performed regression analyses between FDG uptake, CTh, CSF AD biomarkers levels and BMI and interaction analyses with age by obesity/overweight status. Results: We included 147 individuals (mean age 73.3 years, mean BMI 27.4 Kg/m 2 ). Higher BMI was related to less cortical thickness and higher glucose metabolism in brain areas not typically involved in AD (FWE<0.05), with little overlap between them. There was no association between BMI and any of the CSF core AD biomarkers. The relationship between age and brain metabolism was modified by overweight/obesity status, but not that of age and brain structure or core CSF AD biomarkers. Conclusions: Our data support that obesity has differential effects on brain metabolism and structure independent of an underlying AD pathophysiology in cognitively unimpaired elderly.
更多查看译文
关键词
brain metabolism,obesity,amyloid,tau pathology
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要